BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12647431)

  • 21. Migraine headache prophylaxis and treatment with low-dose mirtazapine.
    Lévy E; Margolese HC
    Int Clin Psychopharmacol; 2003 Sep; 18(5):301-3. PubMed ID: 12920393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
    Ruiz-Doblado S; Rueda-Villar T; Zurita-Gotor P; Sanz-Cortes S
    J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological justification for the use of new antidepressant drugs].
    Nowakowska E; Kus K; Bobkiewicz-Kozłowska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):250-2. PubMed ID: 12474581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rapid treatment effect. An effective antidepressant dissolves on the tongue].
    MMW Fortschr Med; 2002 Aug; 144(33-34):53. PubMed ID: 12380147
    [No Abstract]   [Full Text] [Related]  

  • 25. Trait anxiety and the effect of a single high dose of diazepam in unipolar depression.
    Bruijn JA; Moleman P; van den Broek WW; Mulder PG
    J Psychiatr Res; 2001; 35(6):331-7. PubMed ID: 11684140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice.
    Yilmaz I; Sezer Z; Kayir H; Uzbay TI
    Epilepsy Behav; 2007 Aug; 11(1):1-5. PubMed ID: 17517536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant.
    Fraile P; Garcia-Cosmes P; Garcia T; Corbacho L; Alvarez M; Tabernero JM
    Nephrol Dial Transplant; 2009 Jun; 24(6):1999-2001. PubMed ID: 19332869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic dosing with mirtazapine does not produce sedation in rats.
    Salazar-Juárez A; Barbosa-Méndez S; Merino-Reyes P; Matus-Ortega M; Hernández-Calderón JA; Antón B
    Braz J Psychiatry; 2017; 39(3):228-236. PubMed ID: 28355345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats.
    Andrzejczak D; Kocon K; Zieba R
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):450-4. PubMed ID: 18699796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of the use of mirtazapine in the treatment of depression.
    Benjamin S; Doraiswamy PM
    Expert Opin Pharmacother; 2011 Jul; 12(10):1623-32. PubMed ID: 21644844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
    Posey DJ; Guenin KD; Kohn AE; Swiezy NB; McDougle CJ
    J Child Adolesc Psychopharmacol; 2001; 11(3):267-77. PubMed ID: 11642476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase 2 Randomized Dose-Finding Study With Esmirtazapine in Patients With Primary Insomnia.
    Ruwe F; IJzerman-Boon P; Roth T; Zammit G; Ivgy-May N
    J Clin Psychopharmacol; 2016 Oct; 36(5):457-64. PubMed ID: 27482970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics in pharmacokinetics?
    Hartter S
    Am J Psychiatry; 2004 Jul; 161(7):1308-9; author reply 1309. PubMed ID: 15229072
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
    Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacologic profile of mirtazapine.
    de Boer T
    J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of an antidepressant: mirtazapine.
    Preskorn SH
    J Clin Psychiatry; 1997; 58 Suppl 6():3-8. PubMed ID: 9227668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ
    Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tachyphylaxis to the Sedative Action of Mirtazapine.
    Papazisis G; Siafis S; Tzachanis D
    Am J Case Rep; 2018 Apr; 19():410-412. PubMed ID: 29626184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.